JP2006504787A5 - - Google Patents

Download PDF

Info

Publication number
JP2006504787A5
JP2006504787A5 JP2004550230A JP2004550230A JP2006504787A5 JP 2006504787 A5 JP2006504787 A5 JP 2006504787A5 JP 2004550230 A JP2004550230 A JP 2004550230A JP 2004550230 A JP2004550230 A JP 2004550230A JP 2006504787 A5 JP2006504787 A5 JP 2006504787A5
Authority
JP
Japan
Prior art keywords
composition
group
artemisinin
endoperoxide
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004550230A
Other languages
English (en)
Japanese (ja)
Other versions
JP4594734B2 (ja
JP2006504787A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/034431 external-priority patent/WO2004041176A2/en
Publication of JP2006504787A publication Critical patent/JP2006504787A/ja
Publication of JP2006504787A5 publication Critical patent/JP2006504787A5/ja
Application granted granted Critical
Publication of JP4594734B2 publication Critical patent/JP4594734B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004550230A 2002-10-31 2003-10-29 Ｃ型肝炎、牛ウイルス性下痢症及び豚コレラウイルスを含むフラビウイルス科ウイルスにより生起される感染症の治療のためのエンドペルオキシド類の使用 Expired - Fee Related JP4594734B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42268302P 2002-10-31 2002-10-31
PCT/US2003/034431 WO2004041176A2 (en) 2002-10-31 2003-10-29 The use of endoperoxides for the treatment of infections caused by flaviviridae, including hepatitis c, bovine viral diarrhea and classical swine fever virus

Publications (3)

Publication Number Publication Date
JP2006504787A JP2006504787A (ja) 2006-02-09
JP2006504787A5 true JP2006504787A5 (enExample) 2006-09-14
JP4594734B2 JP4594734B2 (ja) 2010-12-08

Family

ID=32312544

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004550230A Expired - Fee Related JP4594734B2 (ja) 2002-10-31 2003-10-29 Ｃ型肝炎、牛ウイルス性下痢症及び豚コレラウイルスを含むフラビウイルス科ウイルスにより生起される感染症の治療のためのエンドペルオキシド類の使用

Country Status (11)

Country Link
US (1) US7842719B2 (enExample)
EP (1) EP1585524B1 (enExample)
JP (1) JP4594734B2 (enExample)
CN (1) CN100430061C (enExample)
AT (1) ATE473745T1 (enExample)
AU (1) AU2003287259A1 (enExample)
CA (1) CA2501584C (enExample)
DE (1) DE60333392D1 (enExample)
ES (1) ES2348536T3 (enExample)
PT (1) PT1585524E (enExample)
WO (1) WO2004041176A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE485039T1 (de) * 2003-02-12 2010-11-15 Univ Georgetown Verwendung von artemisinin zur behandlung von durch onkogene viren gebildeten tumoren und zur behandlung von viralen infektionen
ES2245248B1 (es) * 2004-06-09 2007-02-16 Universidad De Salamanca Uso de la artemisinina y sus derivados en la fabricacion de medicamentos utiles como agentes antiviricos.
KR100824106B1 (ko) * 2006-05-30 2008-04-21 주식회사 씨티씨바이오 흰반점바이러스를 치료 또는 예방하기 위한 조성물 및 방법
WO2008010620A1 (en) * 2006-07-21 2008-01-24 Ben's Lab Co., Ltd. Composition comprising the crude drug extracts for improving liver function
US20080182895A1 (en) * 2006-08-25 2008-07-31 Howe Anita Y M Identification and characterization of hcv replicon variants with reduced susceptibility to hcv-796, and methods related thereto
WO2009155379A2 (en) * 2008-06-17 2009-12-23 Hhv-6 Foundation Artemisinin and derivatives thereof as antivirals
CN102731464B (zh) * 2011-04-12 2014-07-23 沈阳药科大学 一个倍半萜内酯化合物、制备方法及其应用
US20130012470A1 (en) * 2011-07-07 2013-01-10 Humanitas Technology, LLC Antiviral compositions and methods of their use
WO2013006795A2 (en) 2011-07-07 2013-01-10 Humanitas International Foundation Antiviral compositions and methods of their use
DK2838903T3 (en) 2012-04-18 2017-12-11 Univ Hong Kong Sci & Tech Methods and Preparations for Treating Viral Infections
FR2989588A1 (fr) * 2012-04-19 2013-10-25 Centre Nat Rech Scient Composes pour la prevention ou le traitement des infections par des virus de la famille des flaviviridae
CN102755316A (zh) * 2012-07-16 2012-10-31 中国科学院武汉病毒研究所 青蒿素及其衍生物在制备治疗丙型肝炎病毒药物中的应用
US11007272B1 (en) 2016-10-07 2021-05-18 Navidea Biopharmaceuticals, Inc. Compounds and methods for diagnosis and treatment of viral infections
GB201805665D0 (en) * 2018-04-05 2018-05-23 Univ Nottingham Antiviral Compounds And Methods
US20210196676A1 (en) * 2018-05-30 2021-07-01 The Board Of Regents Of The University Of Texas System Treatment of viral infections and virally associated lesions with sequiterpene lactones
CN112245424B (zh) * 2020-10-19 2021-09-21 中国医学科学院医药生物技术研究所 一种没药烷倍半萜结构类似物在制备抗冠状病毒药物中的用途
CN112294795B (zh) * 2020-11-17 2022-03-29 北京化工大学 蒿甲醚在治疗和预防柯萨奇病毒感染中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW198722B (enExample) 1990-05-07 1993-01-21 Hoechst Ag
CN1058717A (zh) * 1990-08-08 1992-02-19 中国人民解放军军事医学科学院微生物流行病研究所 抗疟新药—复方蒿甲醚及其制备方法
CN1105238A (zh) * 1992-11-10 1995-07-19 中国预防医学科学院病毒学研究所 抗aids病毒的药物组合物
CN1035767C (zh) * 1992-11-10 1997-09-03 罗宣德 新的青蒿素衍生物及其用途
EP0713877A1 (en) 1993-07-19 1996-05-29 LUO, Xuande Qinghaosu derivatives against aids
DE4415539C2 (de) * 1994-05-03 1996-08-01 Osama Dr Dr Med Omer Pflanzen mit virustatischer und antiviraler Wirkung
CN1049435C (zh) * 1994-11-09 2000-02-16 中国科学院上海药物研究所 含苯基和杂环基的青蒿素衍生物及其制备方法
DE19902924A1 (de) 1999-01-26 2000-08-03 Hassan Jomaa Verwendung von phosphororganischen Verbindungen zur prophylaktischen und therapeutischen Behandlung von Infektionen
CN1135974C (zh) 2000-08-23 2004-01-28 重庆健桥医药开发有限公司 抗疟药新药复方双氢青蒿素
WO2002032905A1 (en) 2000-10-20 2002-04-25 Ajinomoto Co.,Inc. Medicinal compositions, dose and method for treating malaria
ATE485039T1 (de) * 2003-02-12 2010-11-15 Univ Georgetown Verwendung von artemisinin zur behandlung von durch onkogene viren gebildeten tumoren und zur behandlung von viralen infektionen

Similar Documents

Publication Publication Date Title
JP2006504787A5 (enExample)
JP2002060340A5 (enExample)
JP2004509061A5 (enExample)
DE60131250T8 (de) Nucleosid-analoga mit monozyklischen basischen carboxamidingruppen
JP2009511595A5 (enExample)
JP2004534769A5 (enExample)
JP2010503396A5 (enExample)
JP2008505985A5 (enExample)
JP2007513971A5 (enExample)
CA2413163A1 (en) 3'-prodrugs of 2'-deoxy-.beta.-l-nucleosides
JP2010529835A5 (enExample)
JP2003503454A5 (enExample)
JP2003526662A5 (enExample)
JP2002527052A5 (enExample)
JP2007508234A5 (enExample)
JP2006526031A5 (enExample)
JP2005506087A5 (enExample)
EP2277505A3 (en) Mucoactive agents for treating a pulmonary disease
WO2002032414A3 (en) Ribavirin-pegylated interferon alfa hcv combination therapy
JP2007531741A5 (enExample)
JP2011507972A5 (enExample)
JP2006506097A5 (enExample)
JP2004509837A5 (enExample)
JP4594734B2 (ja) Ｃ型肝炎、牛ウイルス性下痢症及び豚コレラウイルスを含むフラビウイルス科ウイルスにより生起される感染症の治療のためのエンドペルオキシド類の使用
JP2005533800A5 (enExample)